BFA
SGMO

BlackRock Fund Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

BlackRock Fund Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$9.81M Buy
3,215,835
+347,803
+12% +$1.27M ﹤0.01% 2588
2016
Q3 		$13.3M Buy
2,868,032
+154,628
+6% +$786K ﹤0.01% 2305
2016
Q2 		$15.7M Buy
2,713,404
+145,060
+6% +$925K ﹤0.01% 2167
2016
Q1 		$15.5M Buy
2,568,344
+44,746
+2% +$269K ﹤0.01% 2114
2015
Q4 		$23M Sell
2,523,598
-140,184
-5% -$1.08M 0.01% 1952
2015
Q3 		$15M Buy
2,663,782
+101,952
+4% +$841K ﹤0.01% 2168
2015
Q2 		$28.4M Sell
2,561,830
-43,871
-2% -$566K 0.01% 1897
2015
Q1 		$40.9M Buy
2,605,701
+70,695
+3% +$1.09M 0.01% 1648
2014
Q4 		$38.6M Buy
2,535,006
+234,277
+10% +$2.84M 0.01% 1639
2014
Q3 		$24.8M Sell
2,300,729
-6,203
-0.3% -$81K 0.01% 1820
2014
Q2 		$35.2M Sell
2,306,932
-324,722
-12% -$4.67M 0.01% 1643
2014
Q1 		$47.6M Buy
2,631,654
+267,093
+11% +$5.15M 0.01% 1450
2013
Q4 		$32.8M Buy
2,364,561
+57,312
+2% +$660K 0.01% 1684
2013
Q3 		$24.2M Buy
2,307,249
+467,028
+25% +$4.64M 0.01% 1838
2013
Q2 		$14.4M Buy
+1,840,221
New +$16.1M 0.01% 2042

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock Fund Advisors's SGMO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 12% in Q4 2016, buying an estimated $1.27M and bringing the position to 3,215,835 shares worth $9.81M. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

BlackRock Fund Advisors first reported a position in SGMO in Q2 2013 and has held it in 15 quarters since. The position peaked at $47.6M in Q1 2014. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

  • BlackRock Fund Advisors held 3,215,835 shares of SANGAMO THERAPEUTICS INC worth $9.81M as of Q4 2016.
  • BlackRock Fund Advisors bought 347,803 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $1.27M.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2588 holding.
  • BlackRock Fund Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's SANGAMO THERAPEUTICS INC position peaked at $47.6M in Q1 2014.
  • 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.